Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer

Urokinase-type plasminogen activator receptor (uPAR) is an attractive target for the treatment of cancer, because it is expressed at low levels in healthy tissues but at high levels in malignant tumours. uPAR is closely related to the invasion and metastasis of malignant tumours, plays important rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Bing-Tao, Tian, Huan, Sun, Jing, Zou, Jun-Bo, Zhang, Xiao-Fei, Cheng, Jiang-Xue, Shi, Ya-Jun, Fan, Yu, Guo, Dong-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932206/
https://www.ncbi.nlm.nih.gov/pubmed/35303878
http://dx.doi.org/10.1186/s12967-022-03329-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932206/
https://www.ncbi.nlm.nih.gov/pubmed/35303878
http://dx.doi.org/10.1186/s12967-022-03329-3

Ejemplares similares